Poseida Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Poseida Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Poseida Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $201M, a 24.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $201M +$39.3M +24.2% Dec 31, 2023 10-K 2024-03-07
Q4 2022 $162M +$20.3M +14.3% Dec 31, 2022 10-K 2024-03-07
Q4 2021 $142M +$50.7M +55.6% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $91.1M +$43.1M +89.7% Dec 31, 2020 10-K 2022-03-10
Q4 2019 $48M Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.